Effect of drugs that suppress platelet surface interaction on incidence of amaurosis fugax and transient cerebral ishcemia.
D001766:Blindness / Q000517:prevention & control*; D001792:Blood Platelets / Q000187:drug effects*; D002986:Clinical Trials as Topic; D006801:Humans; D002546:Ischemic Attack, Transient / Q000517:prevention & control*; D010919:Placebos; D013442:Sulfinpyrazone / Q000627:therapeutic use
D010919:Placebos; D013442:Sulfinpyrazone